Monitoring –Second assessment completed – letter not sent

MA- Monitoring-Expired

Back to Dashboard

No. Reference No. Brand Name Generic Name GMP Status Assessment Pathway Application Date Date 1st Assessment Date 2nd Assessment Time monitor
13142/2019CONTUS PLUS PAEDIATRIC SUSPENSION)CHLORPHENAMINE,PHENYLEPHINE&PARACETAMOL SUSPENSION APPLIED FOR GMP FULL ASSESSMENT 2019-08-27
Round-1
2021-11-022021-11-03943 days
215706/2022CYTOSUNMISOPROSTOL GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2022-10-21
Application Date
2024-04-182024-05-16578 days
32846/2019EMITINO INJECTIONONDANSETRON INJECTION USP 2MG/ML APPLIED FOR GMP FULL ASSESSMENT 2019-08-06
Round-1
2021-04-132021-04-191,188 days
45422/2018FEMIGESTON-100PROGESTERONE BP NOT APPLIED FULL ASSESSMENT 2019-02-27
Round-1
2021-06-182021-06-241,083 days
58727/2017KCHEKCALCIUM POLYSTYRENE SULFONATE APPLIED FOR GMP FULL ASSESSMENT 2018-02-10
Round-1
2021-05-072021-05-251,123 days
613949/2022MEXINE 200MGCIMETIDINE GMP CERTIFICATE AVAILABLE ABRIDGED 2022-09-23
Application Date
2024-04-190000-00-00606 days
72932/2021MYGLIP PLUS 2.5/1000LINAGLIPTIN/METFORMIN HYDROCHLORIDE NOT APPLIED FULL ASSESSMENT 2021-04-26
Round-1
2022-08-252023-03-08780 days
82934/2021MYGLIP PLUS 2.5/500LINAGLIPTIN/METFORMIN HYDROCHLORIDE NOT APPLIED FULL ASSESSMENT 2021-04-26
Application Date
2023-12-032023-12-131,121 days
92631/2023P ALAXIN DS 80/640DIHYDROARTEMISININ/ PIPERAQUIN PHOSPHATE GMP CERTIFICATE AVAILABLE FULL ASSESSMENT 2023-02-24
Application Date
2024-05-032024-05-16452 days
107928/2017SAPHIR INFANTSAMOXICILLIN & CLAVULANIC ACID NOT APPLIED FULL ASSESSMENT
Round-3
2022-05-092022-05-09844 days
110437/2019TERBINAFINE 250 TABLETSTERBINAFINE HYDROCHLORIDE NOT APPLIED FULL ASSESSMENT 2019-02-14
Round-2
2021-10-280000-00-00966 days